Research Services

Claims Substantiation/Product Use Studies

Our robust clinical research platform incorporates outcomes and photography to support claims substantiations for cosmetic, consumer products, over-the-counter and prescription drugs and devices for the skin. Types of claims typically substantiated by KGL include:

Dermatologist Tested
Clinically Tested
Allergy Tested
Hypoallergenic
Skin Types Desirability
Non-Irritating
Non-Stinging
Non-Photosensitizing
Formulated for Sensitive Skin
Reduction of Fine Lines / Wrinkles
Skin Brightening, Lightening or Smoothing
Cleanses & Moisturizes
Noncomedogenic / Non-Acnegenic
Anti-Inflammatory
Anti-Itch

Safety Patch Testing

KGL conducts a variety of repeat insult patch testing (RIPT) for assessing safety and tolerability for use on human skin. Many of which were developed by the founder of KGL, Dr. Albert M. Kligman. These types of studies remain the industry standard for new ingredient and product testing:

Allergenicity
Photosensitivity
Irritancy
Acnegenicity/Comedogenicity
Pruritus
Cell Turnover

Clinical Trials (Phase II – IV)

KGL’s large database and board-certified medical specialists makes us well suited for conducting phase II through IV clinical trials in diverse populations and study types

Aging Skin
Eczema/Atopic Dermatitis
Acne
Rosacea
Psoriasis
Vitiligo
Warts /Molluscum
Aesthetic Devices and Injectables

Proof of Concept Studies

Small studies to demonstrate efficacy and/or safety prior to large scale testing are often useful starting points in commercial development. KGL has experience in designing and conducting proof of concept studies for a wide array of indications with both novel and customizable endpoints. Skin biopsy tissue acquisition provides analysis for:

Histology
Immunohistochemistry
DNA, RNA, Protein
Microbiology